Liver cancer is one of the most common malignant tumors. Chemotherapy drugs have been widely used in the anti-hepatoma research. However, low targeting efficiency and serious adverse reaction are their main drawbacks. Liver tumor was proved to have a slightly acidic microenvironment (pH 4.5–5.5) and many glycyrrhetinic-acid-specific binding sites. Therefore, in the present study, the glycyrrhetinic acid- and hydrazone bond-modified micelles were designed. mPEG-HZ-PLA and GA-PEG-PLA copolymer were synthesized to prepare glycyrrhetinic-acid-modified pH-sensitive polymeric micelles (GA-PEG-HZ-PLA). The targeted pharmacokinetics was used to evaluate the effect in hepatoma 22 tumor-bearing mice after the micelles were administered intravenously. The contents of coumarin-6 in blood and tissues were determined through high-performance liquid chromatography using a fluorescence detection (HPLC-FLD) with coumarin-30 as inner standard. The micelles have shown long-circulation effects and two-department models. In the targeting pharmacokinetics, the relative intake efficiency, targeted efficiency, relative targeting efficiency, and concentration ratio of GA-PEG-HZ-PLA in the tumor were 3.24, 4.04, 3.00, and 2.47, respectively. We have demonstrated that GA-PEG-HZ-PLA was more effectively accumulated in the liver and tumor. Thus, the prepared active-targeted and pH-sensitive micelles modified with glycyrrhetinic acid structure and hydrazone bond are promising tools for effective liver cancer therapy.
PetrickJLBraunlinMLaversanneMet al.
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007. Int J Cancer2016;
139: 1534–1545.
2.
SunYQLuJHYanDXet al.
Cellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid-modified liposome in hepatocellular carcinoma cells. Environ Toxicol Pharmacol2017;
53: 46–56.
3.
KawaguchiYHondaGEndoIet al.
Current technical issues for surgery of primary liver cancer. Liver Cancer2017;
6: 51–58.
4.
WuHYYuTYTianYet al.
Enhanced liver-targeting via coadministration of 10-hydroxycamptothecin polymeric micelles with vinegar baked Radix Bupleuri. Phytomedicine2018;
44: 1–8.
5.
MaYKFanXHLiLB.pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel. Carbohydr Polym2016;
137: 19–29.
6.
YinYTFuCPLiMPet al.
A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment. Mater Sci Eng C Mater Biol Appl2016;
67: 159–169.
7.
LiuYLiJLiZet al.
Pharmacokinetics of a ternary conjugate based pH-responsive 10-HCPT prodrug nano-micelle delivery system. Asia J Pharm Sci2017;
12: 542–549.
8.
LiuNLiBQGongCet al.
A pH- and thermo-responsive poly(amino acid)-based drug delivery system. Colloids Surf B Biointerfaces2015;
136: 562–569.
9.
HeQJGaoYZhangLXet al.
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials2011;
32: 7711–7720.
10.
PontaABaeY.PEG-poly (amino acid) block copolymer micelles for tunable drug release. Pharm Res2010;
27: 2330–2342.
11.
BaeYNishiyamaNKataokaK.In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem2007;
18: 1131–1139.
12.
CaoJSuTZhangLGet al.
Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery. Int J Pharm2014;
471: 28–36.
13.
NieSYLinWJYaoNet al.
Drug release from pH-sensitive polymeric micelles with different drug distributions: insight from coarse-grained simulations. ACS Appl Mater Interfaces2014;
6: 17668–17678.
14.
EtrychTMrkvanTChytilPet al.
N-(2-hydroxypropyl) methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation. J Appl Polym Sci2008;
109: 3050–3061.
15.
EtrychTKovářLStrohalmJet al.
Biodegradable star HPMA polymer-drug conjugates: biodegradability, distribution and anti-tumor efficacy. J Control Release2011;
154: 527–539.
16.
KonoKKojimaCHayashiNet al.
Preparation and cytotoxic activity of poly (ethylene glycol)-modified poly (amidoamine) dendrimers bearing adriamycin. Biomaterials2008;
29: 1664–1675.
17.
DanhierFFeronOPréatV.To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release2010;
148: 135–146.
ParkJJinPJuEJet al.
Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging. J Control Release2015;
207: 77–85.
20.
ChenQDingHWZhouJXet al.
Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities. RSC Adv2016;
6: 17782–17791.
21.
ZhangHJiangYNiXLet al.
Glycyrrhetinic acid-modified norcantharidin nanoparticles for active targeted therapy of hepatocellular carcinoma. J Biomed Nanotechnol2018;
14: 114–126.
22.
SinghHKimSJKangDHet al.
Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity. Chem Commun (Camb)2018;
54: 12353–12356.
23.
UrsoRBlardiPGiorgiG.A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci2002;
6: 33–44.
24.
ChenJNLiSSShenQ.Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery. Eur J Pharm Sci2012;
47: 430–443.
25.
JinJSuiBWGouJXet al.
PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells. PLoS One2014;
9: e112200.
26.
TuYSSunDMZhangJJet al.
Preparation and characterisation of andrographolide niosomes and its anti-hepatocellular carcinoma activity. J Microencapsul2014;
31: 307–316.
27.
WangMYuanYGaoYet al.
Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo. Drug Dev Ind Pharm2011;
38: 1134–1141.
28.
GaoMYaoNHuangDJet al.
Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model: in vivo magnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy. J Drug Target2015;
23: 436–443.
29.
LuoLHChenYCChengYet al.
Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase. Drug Deliv2016;
23: 1282–2.
30.
GuoBHChengYLiNYet al.
In vitro and in vivo studies of galactose-modified liver-targeting liposomes. J Drug Target2013;
21: 257–264.
31.
GuptaRSheaJScafeCet al.
Polymeric micelles and nanoemulsions as drug carriers: therapeutic efficacy, toxicity, and drug resistance. J Control Release2015;
212: 70–77.
32.
UlbrichKSubrV.Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev2004;
56: 1023–1050.
33.
QiPLWuXHLiuLet al.
Hydrazone-containing triblock copolymeric micelles for pH-controlled drug delivery. Front Pharmacol2018;
9: 12.
34.
ChytilPŠÍrováMKudláčOváJet al.
Bloodstream stability predetermines the antitumor efficacy of micellar polymer–doxorubicin drug conjugates with pH-triggered drug release. Mol Pharm2018;
15: 3654–3663.
35.
YangXQPillaSGrailerJJet al.
Tumor-targeting, superparamagnetic polymeric vesicles as highly efficient MRI contrast probes. J Mater Chem2009;
19: 5812–5817.
36.
ZhangLJKuangYZhuoRXet al.
Anionic long circulating liposomes for hepatic targeted delivery of cisplatin. J Control Release2015;
213: e72.
37.
ZhangJMZhangMJiJet al.
Glycyrrhetinic acid-mediated polymeric drug delivery targeting the acidic microenvironment of hepatocellular carcinoma. Pharm Res2015;
32: 3376–3390.
38.
HartlandALeadJRSlaveykovaVIet al.
The environmental significance of natural nanoparticles. Nat Educ Knowl2013;
4: 7.
39.
GiepmansBNAdamsSREllismanMHet al.
The fluorescent toolbox for assessing protein location and function. Science2006;
312: 217–224.
40.
RivoltaIPanaritiALettieroBet al.
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol2011;
62: 45–53.
41.
ChenJChenYCChengYet al.
Glycyrrhetinic acid liposomes containing mannose-diester lauric diacid-cholesterol conjugate synthesized by lipase-catalytic acylation for liver-specific delivery. Molecules2017;
22: 1598.
42.
ChenJDJiangHWuYet al.
A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation. Drug Des Devel Ther2015;
9: 2265–2275.
43.
WeiYMLiangJZhengXLet al.
Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer. Int J Nanomedicine2017;
12: 251–261.
